Emergency Management of Pediatric Status Asthmaticus – Evidence‑Based Recommendations

1. Initial Recognition and Severity Assessment

• Children with acute severe asthma are identified by an inability to speak or feed, a respiratory rate > 50 breaths/min, a pulse > 140 beats/min, and a peak expiratory flow (PEF) < 50 % of predicted. 1, 2, 3
• Life‑threatening features that mandate immediate ICU consideration include PEF < 33 % predicted or poor respiratory effort, cyanosis, a silent chest, marked exhaustion, and altered mental status (agitation or reduced consciousness). 1, 2, 3

2. Immediate First‑Line Treatment (First 15–30 min)

2.1 Oxygen Therapy

• Deliver high‑flow oxygen (40–60 % FiO₂) via face mask and titrate to maintain peripheral SaO₂ > 92 %; continuous pulse‑oximetry is required throughout resuscitation. 1, 2

2.2 Bronchodilator Therapy

• Administer nebulized salbutamol 5 mg (or 2.5 mg if age ≤ 2 years); in very young children use half‑dose regimens. 1, 2, 3
• Add ipratropium bromide 100 µg to the nebulizer immediately and repeat every 6 hours; this combination reduces hospitalisation rates, especially in severe airflow obstruction. 1, 2

2.3 Systemic Corticosteroid Therapy

• Give oral prednisolone 1–2 mg/kg (maximum 60 mg) as a single dose when the child can swallow. 1
• If the child is vomiting, severely ill, or unable to take oral medication, provide intravenous hydrocortisone 200 mg every 6 hours (or 4 mg/kg per dose). 1

3. Early Reassessment (15–30 min)

• Repeat PEF measurement and clinical assessment after each bronchodilator dose; chart PEF before and after β‑agonist administration at least four times daily. 1, 2

3.1 If Clinical Improvement Is Observed

• Continue high‑flow oxygen to keep SaO₂ > 92 %. 1
• Maintain oral prednisolone 1–2 mg/kg daily (max 40–60 mg). 1
• Provide nebulized β‑agonist every 4 hours. 1

3.2 If No Improvement After 15–30 min

• Increase nebulized β‑agonist frequency to every 30 minutes. 1, 2
• Ensure ipratropium bromide is administered every 6 hours. 1, 2
• Continue oxygen and systemic steroids. 1, 2

4. Second‑Line Therapies for Persistent or Life‑Threatening Features

• Initiate intravenous aminophylline with a loading dose of 5 mg/kg over 20 minutes followed by a maintenance infusion of 1 mg/kg/hour; omit the loading dose if the child is already receiving oral theophyllines. 1, 2, 3

5. Criteria for ICU Transfer

• Deteriorating PEF despite aggressive therapy. 1, 2, 3
• Worsening exhaustion or feeble respirations. 1, 2, 3
• Persistent hypoxia (SaO₂ < 92 %) despite high‑flow oxygen or evidence of hypercapnia. 1, 2, 3
• Altered mental status (confusion, drowsiness, coma) or respiratory arrest. 1, 2, 3

6. Discharge Planning

• Child must have been on discharge medications for at least 24 hours with demonstrated correct inhaler technique. 1
• PEF should be > 75 % of predicted with diurnal variability < 25 %. 1
• Discharge regimen must include oral prednisolone 1–2 mg/kg daily for 3–5 days, an inhaled corticosteroid, and a short‑acting bronchodilator. 1
• Provide a written asthma action plan to caregivers. 1
• Arrange general‑practice follow‑up within 1 week and respiratory‑clinic review within 4 weeks. 1

7. Ongoing In‑Hospital Monitoring

• Continuous pulse‑oximetry with target SaO₂ > 92 %. 1
• Record PEF before and after each β‑agonist dose, minimum four times daily. 1, 2
• Routine arterial blood‑gas analysis is rarely useful for initial management decisions in children. 1, 2, 3

Status Asthmaticus Management

Initial Assessment and Treatment

• The American Thoracic Society recommends immediate administration of high-flow oxygen to maintain oxygen saturation >92% in patients with status asthmaticus 4, 5
• Life-threatening features requiring immediate ICU consideration include silent chest, cyanosis, poor respiratory effort, exhaustion, altered consciousness, or agitation 5
• Severe asthma indicators in a 7-year-old include inability to complete sentences in one breath, respiratory rate >50/min, pulse >140/min, peak expiratory flow <50% predicted 4, 5
• Assess oxygen saturation immediately and maintain >92% throughout treatment 4, 5

Immediate Treatment Protocol

• High-flow oxygen via face mask at 40-60% to maintain SaO₂ >92% is recommended by the British Thoracic Society 6, 4, 5
• Nebulized salbutamol 5 mg via oxygen-driven nebulizer is recommended as first-line therapy 4
• Oral prednisolone 1-2 mg/kg as a single dose (maximum 60 mg) is recommended by the American Academy of Pediatrics 4
• Ipratropium bromide 100 mcg added to nebulizer immediately, then repeated every 6 hours, is recommended by the American College of Chest Physicians 4, 5

Monitoring and Reassessment

• Repeat peak expiratory flow measurement before and after each bronchodilator dose, as recommended by the National Asthma Education and Prevention Program 4, 5
• Continuous pulse oximetry with target >92% is recommended by the American Thoracic Society 4
• Reassess clinical features, including work of breathing, air entry, ability to speak, and vital signs, as recommended by the British Thoracic Society 5

Hospital Admission Criteria

• Admit if any of the following persist after initial treatment: life-threatening features, peak expiratory flow remains <50% predicted, persistent features of severe asthma, as recommended by the American Academy of Pediatrics 4, 5, 7

ICU Transfer Indications

• Transfer to ICU immediately if deteriorating peak flow despite aggressive treatment, worsening exhaustion or feeble respirations, persistent hypoxia despite high-flow oxygen, or development of confusion, drowsiness, or altered consciousness, as recommended by the Society of Critical Care Medicine 5, 6

Ongoing Management

• Continue high-flow oxygen to maintain SaO₂ >92%, as recommended by the American Thoracic Society 4
• Continue prednisolone 1-2 mg/kg daily, as recommended by the American Academy of Pediatrics 4
• Nebulized β-agonist every 4 hours, as recommended by the National Asthma Education and Prevention Program 4

Discharge Criteria

• Child must meet all criteria, including on discharge medications for 24 hours with proper inhaler technique demonstrated, peak flow >75% of predicted with diurnal variability <25%, treatment plan includes oral steroids, inhaled corticosteroids, and bronchodilators, written action plan provided to parents, GP follow-up arranged within 1 week, and respiratory clinic follow-up within 4 weeks, as recommended by the American Academy of Pediatrics 4, 5, 7